Chronic treatment with naltrexone enhances morphine-stimulated dopamine neurotransmission: Neurochemical and behavioral evidence

M. T. Bardo, Janet Neisewander, R. B. Ennis

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Rats were implanted for 10 days with a slow-release pellet of naltrexone or were given sham surgery. At one of various different intervals during or after implantation of the pellet, the synthesis of dopamine (DA) was assessed in the nigrostriatal and mesolimbic systems. The results indicated that naltrexone alone was without effect on the synthesis of DA. However, one day after removal of the pellet, naltrexone-treated animals displayed an enhanced response to the DA-stimulatory action of morphine (15 mg/kg) in both the nigrostriatal and mesolimbic systems. This change was accompanied by an increase in specific binding of the μ-specific radioligand [3H]DAGO in whole brain and by an increase in the depressant action of morphine on locomotor activity. In contrast, at 10 days after removal of the pellet, naltrexone was without effect on morphine-induced changes in the synthesis of DA and locomotor activity, thus indicating that the supersensitivity to morphine was transient. These results support the idea that opioids modulate DAergic neurotransmission in the nigrostriatal and mesolimbic pathways and that this modulatory role may underlie opiate-induced changes in locomotor behavior.

Original languageEnglish (US)
Pages (from-to)1103-1109
Number of pages7
JournalNeuropharmacology
Volume27
Issue number11
DOIs
StatePublished - 1988
Externally publishedYes

Fingerprint

Naltrexone
Synaptic Transmission
Morphine
Dopamine
Locomotion
Opiate Alkaloids
Ala(2)-MePhe(4)-Gly(5)-enkephalin
Opioid Analgesics
Brain

Keywords

  • dopamine
  • locomotor activity
  • mesolimbic system
  • morphine
  • naltrexone
  • nigrostratal system

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

Chronic treatment with naltrexone enhances morphine-stimulated dopamine neurotransmission : Neurochemical and behavioral evidence. / Bardo, M. T.; Neisewander, Janet; Ennis, R. B.

In: Neuropharmacology, Vol. 27, No. 11, 1988, p. 1103-1109.

Research output: Contribution to journalArticle

@article{a90bbc441c4b4a45ab039eb3d85444c5,
title = "Chronic treatment with naltrexone enhances morphine-stimulated dopamine neurotransmission: Neurochemical and behavioral evidence",
abstract = "Rats were implanted for 10 days with a slow-release pellet of naltrexone or were given sham surgery. At one of various different intervals during or after implantation of the pellet, the synthesis of dopamine (DA) was assessed in the nigrostriatal and mesolimbic systems. The results indicated that naltrexone alone was without effect on the synthesis of DA. However, one day after removal of the pellet, naltrexone-treated animals displayed an enhanced response to the DA-stimulatory action of morphine (15 mg/kg) in both the nigrostriatal and mesolimbic systems. This change was accompanied by an increase in specific binding of the μ-specific radioligand [3H]DAGO in whole brain and by an increase in the depressant action of morphine on locomotor activity. In contrast, at 10 days after removal of the pellet, naltrexone was without effect on morphine-induced changes in the synthesis of DA and locomotor activity, thus indicating that the supersensitivity to morphine was transient. These results support the idea that opioids modulate DAergic neurotransmission in the nigrostriatal and mesolimbic pathways and that this modulatory role may underlie opiate-induced changes in locomotor behavior.",
keywords = "dopamine, locomotor activity, mesolimbic system, morphine, naltrexone, nigrostratal system",
author = "Bardo, {M. T.} and Janet Neisewander and Ennis, {R. B.}",
year = "1988",
doi = "10.1016/0028-3908(88)90004-4",
language = "English (US)",
volume = "27",
pages = "1103--1109",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "11",

}

TY - JOUR

T1 - Chronic treatment with naltrexone enhances morphine-stimulated dopamine neurotransmission

T2 - Neurochemical and behavioral evidence

AU - Bardo, M. T.

AU - Neisewander, Janet

AU - Ennis, R. B.

PY - 1988

Y1 - 1988

N2 - Rats were implanted for 10 days with a slow-release pellet of naltrexone or were given sham surgery. At one of various different intervals during or after implantation of the pellet, the synthesis of dopamine (DA) was assessed in the nigrostriatal and mesolimbic systems. The results indicated that naltrexone alone was without effect on the synthesis of DA. However, one day after removal of the pellet, naltrexone-treated animals displayed an enhanced response to the DA-stimulatory action of morphine (15 mg/kg) in both the nigrostriatal and mesolimbic systems. This change was accompanied by an increase in specific binding of the μ-specific radioligand [3H]DAGO in whole brain and by an increase in the depressant action of morphine on locomotor activity. In contrast, at 10 days after removal of the pellet, naltrexone was without effect on morphine-induced changes in the synthesis of DA and locomotor activity, thus indicating that the supersensitivity to morphine was transient. These results support the idea that opioids modulate DAergic neurotransmission in the nigrostriatal and mesolimbic pathways and that this modulatory role may underlie opiate-induced changes in locomotor behavior.

AB - Rats were implanted for 10 days with a slow-release pellet of naltrexone or were given sham surgery. At one of various different intervals during or after implantation of the pellet, the synthesis of dopamine (DA) was assessed in the nigrostriatal and mesolimbic systems. The results indicated that naltrexone alone was without effect on the synthesis of DA. However, one day after removal of the pellet, naltrexone-treated animals displayed an enhanced response to the DA-stimulatory action of morphine (15 mg/kg) in both the nigrostriatal and mesolimbic systems. This change was accompanied by an increase in specific binding of the μ-specific radioligand [3H]DAGO in whole brain and by an increase in the depressant action of morphine on locomotor activity. In contrast, at 10 days after removal of the pellet, naltrexone was without effect on morphine-induced changes in the synthesis of DA and locomotor activity, thus indicating that the supersensitivity to morphine was transient. These results support the idea that opioids modulate DAergic neurotransmission in the nigrostriatal and mesolimbic pathways and that this modulatory role may underlie opiate-induced changes in locomotor behavior.

KW - dopamine

KW - locomotor activity

KW - mesolimbic system

KW - morphine

KW - naltrexone

KW - nigrostratal system

UR - http://www.scopus.com/inward/record.url?scp=0023701564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023701564&partnerID=8YFLogxK

U2 - 10.1016/0028-3908(88)90004-4

DO - 10.1016/0028-3908(88)90004-4

M3 - Article

C2 - 2849725

AN - SCOPUS:0023701564

VL - 27

SP - 1103

EP - 1109

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 11

ER -